This firm's average rating is Buy from 4 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Afya market sentiment investors' perception of the future value of Afya. Let us look at a few aspects of Afya technical analysis.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of Afya. In general, sophisticated investors focus on analyzing Afya stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build Afya's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of
Afya's intrinsic value. In addition to deriving basic predictive indicators for Afya, many experienced traders also check how macroeconomic factors affect Afya price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Afya's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Afya. Your research has to be compared to or analyzed against Afya's peers to derive any actionable benefits. When done correctly, Afya's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Afya.
How does Afya Stands against Peers?
Analyzing Afya competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Afya across multiple sectors and
thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out
Afya Competition DetailsAfya Gross Profit
Afya Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Afya previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Afya Gross Profit growth over the last 10 years. Please check Afya's
gross profit and other
fundamental indicators for more details.
Closer look at Afya Mean Deviation
Afya Ltd Cl has current Mean Deviation of 2.42. The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns.
Mean Deviation is the average of the absolute values of the differences between price distribution numbers and their mean. Mean deviation of equity instrument with a lot of historical data is a biased estimator because the time horizon used in calculation will always be much smaller than the entire price history of the equity. The mean deviation is typically used as a measure of dispersion for small investment horizon, otherwise standard deviation is a better measure of dispersion.
Mean Deviation | = | SUM(RET DEV) N |
| = | 2.42 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Afya |
| N | = | Number of calculation points for selected time horizon |
Our perspective of the current Afya slip
The potential upside is down to 4.95 as of today.
As of the 22nd of August, Afya shows the Downside Deviation of 3.25,
risk adjusted performance of 0.0515, and Mean Deviation of 2.42. Afya Ltd Cl
technical analysis gives you the methodology to make use of
historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of
historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen
technical drivers for Afya Ltd Cl, which can be compared to its rivals. Please confirm
Afya Ltd Cl value at risk, as well as the
relationship between the semi variance and
kurtosis to decide if Afya Ltd Cl is priced correctly, providing market reflects its regular price of 12.36 per share. Given that Afya has
jensen alpha of 0.0392, we suggest you to validate Afya Ltd Cl's prevailing market performance to make sure the company can sustain itself at a future point.
Our Bottom Line On Afya Ltd Cl
Whereas other companies within the education & training services industry are still a little expensive, even after the recent corrections, Afya may offer a potential longer-term growth to investors. To conclude, as of the 22nd of August 2022, we believe that at this point, Afya is
undervalued with
below average probability of distress within the next 2 years. Our latest buy-hold-sell recommendation on the company is
Cautious Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Afya. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com